TickerFacts.

A business in context

NWBO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-097188

  2. 8-K · Current report

    Report date 2026-07-29 · 0001104659-26-089293 · Items 1.01,2.03

  3. 8-K · Current report

    Report date 2026-07-17 · 0001104659-26-084743 · Items 7.01

  4. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-062661

  5. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-043806

  6. 8-K · Current report

    Report date 2025-10-24 · 0001104659-26-040260 · Items 2.01

  7. 8-K · Current report

    Report date 2026-01-15 · 0001104659-26-004146 · Items 8.01

  8. 8-K · Current report

    Report date 2025-12-29 · 0001104659-26-000243 · Items 5.03,5.07,9.01

  9. DEF 14A · Proxy statement

    Report date 2025-12-29 · 0001104659-25-116966

  10. 8-K · Current report

    Report date 2025-11-14 · 0001104659-25-114627 · Items 1.01,2.03

  11. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-112676

  12. 8-K · Current report

    Report date 2025-10-27 · 0001104659-25-104812 · Items 1.01,2.03

  13. 8-K · Current report

    Report date 2025-10-24 · 0001104659-25-104427 · Items 1.01

  14. 8-K · Current report

    Report date 2025-10-23 · 0001104659-25-102049 · Items 8.01

  15. 8-K · Current report

    Report date 2025-10-09 · 0001104659-25-099196 · Items 8.01

  16. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001410578-25-001825

  17. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001410578-25-001333

  18. 10-K · Annual report

    Report date 2024-12-31 · 0001410578-25-000598

  19. 8-K · Current report

    Report date 2024-12-19 · 0001104659-24-131723 · Items 1.01,2.03,9.01

  20. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001410578-24-001879

  21. 8-K · Current report

    Report date 2024-10-31 · 0001104659-24-113553 · Items 1.01,2.03

  22. 4 · Ownership change

    Report date 2024-08-29 · 0001104659-24-096354

  23. 4 · Ownership change

    Report date 2024-08-09 · 0001104659-24-088927

  24. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001410578-24-001278

  25. 4 · Ownership change

    Report date 2024-08-08 · 0001104659-24-087304

  26. 8-K · Current report

    Report date 2024-08-02 · 0001104659-24-085198 · Items 7.01

  27. 4 · Ownership change

    Report date 2024-07-26 · 0001104659-24-084069

  28. 8-K · Current report

    Report date 2024-06-29 · 0001104659-24-077718 · Items 5.07

  29. 8-K · Current report

    Report date 2024-05-31 · 0001104659-24-068314 · Items 1.01

  30. DEF 14A · Proxy statement

    Report date 2024-06-29 · 0001104659-24-067885

  31. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001410578-24-000741

  32. 8-K · Current report

    Report date 2024-04-26 · 0001104659-24-056424 · Items 1.01,2.03

  33. 10-K/A · Annual report

    Report date 2023-12-31 · 0001104659-24-054153

  34. 8-K · Current report

    Report date 2024-03-18 · 0001104659-24-037901 · Items 5.02

  35. 8-K · Current report

    Report date 2024-03-08 · 0001104659-24-034527 · Items 5.02

  36. 10-K · Annual report

    Report date 2023-12-31 · 0001410578-24-000133

  37. 4 · Ownership change

    Report date 2023-11-16 · 0001104659-23-122940

  38. 4 · Ownership change

    Report date 2023-04-03 · 0001104659-23-042303

  39. 4 · Ownership change

    Report date 2023-04-04 · 0001104659-23-041927

  40. 4 · Ownership change

    Report date 2022-12-01 · 0001104659-22-124667

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001072379NORTHWEST BIOTHERAPEUTICS INC

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5493002DRWWEOWTT8005
GLEIF legal name
NORTHWEST BIOTHERAPEUTICS, INC.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2026-06-05T15:56:20Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Northwest Biotherapeutics · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$1.38M$1.47M
2023-12-31$1.93M$2.12M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗